Statera Biopharma, Inc. Quarterly Operating Lease, Liability in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Statera Biopharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2021 to Q3 2022.
  • Statera Biopharma, Inc. Operating Lease, Liability for the quarter ending September 30, 2022 was $1.01M, a 7.92% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $1.01M +$74.1K +7.92% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.14M Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $1.22M Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $1.09M Dec 31, 2021 10-K 2022-10-06
Q3 2021 $936K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.